NHS :: Bioscience responds to Oft report on NHS Pharmaceutical Price Regulation Scheme
The Office of Fair Trading (OFT) market study has today recommended a fundamental reform of the drug pricing system in the UK, which would see the current profit and price controls replaced with a value-based approach to pricing.